Brahim Achour

2.5k total citations
67 papers, 2.0k citations indexed

About

Brahim Achour is a scholar working on Pharmacology, Oncology and Spectroscopy. According to data from OpenAlex, Brahim Achour has authored 67 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 34 papers in Oncology and 19 papers in Spectroscopy. Recurrent topics in Brahim Achour's work include Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (33 papers) and Advanced Proteomics Techniques and Applications (13 papers). Brahim Achour is often cited by papers focused on Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (33 papers) and Advanced Proteomics Techniques and Applications (13 papers). Brahim Achour collaborates with scholars based in United Kingdom, United States and Egypt. Brahim Achour's co-authors include Amin Rostami‐Hodjegan, Jill Barber, Zubida M. Al‐Majdoub, Matthew R. Russell, Matthew D. Harwood, Narciso Couto, Eman El‐Khateeb, Gordon Carlson, Sibylle Neuhoff and Aleksandra Galetin and has published in prestigious journals such as FEBS Letters, Journal of Neurochemistry and The Annual Review of Pharmacology and Toxicology.

In The Last Decade

Brahim Achour

61 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brahim Achour United Kingdom 25 938 903 560 371 325 67 2.0k
David R. Jones United States 19 979 1.0× 765 0.8× 576 1.0× 311 0.8× 118 0.4× 35 2.3k
Sibylle Neuhoff United Kingdom 30 968 1.0× 1.6k 1.7× 503 0.9× 794 2.1× 331 1.0× 68 2.8k
A. David Rodrigues United States 26 924 1.0× 772 0.9× 416 0.7× 328 0.9× 118 0.4× 49 1.8k
Laurent Salphati United States 30 935 1.0× 1.7k 1.9× 876 1.6× 777 2.1× 174 0.5× 67 2.9k
A. David Rodrigues United States 31 1.1k 1.2× 1.3k 1.5× 444 0.8× 647 1.7× 154 0.5× 73 2.5k
Robin E. Pearce United States 29 1.3k 1.4× 621 0.7× 467 0.8× 631 1.7× 151 0.5× 58 2.4k
Theunis C. Goosen United States 30 1.8k 2.0× 1.2k 1.3× 756 1.4× 514 1.4× 241 0.7× 62 3.0k
Toshiro Niwa Japan 27 1.1k 1.1× 505 0.6× 452 0.8× 220 0.6× 141 0.4× 98 2.2k
Kathryn E. Kenworthy United Kingdom 15 771 0.8× 1.0k 1.2× 302 0.5× 557 1.5× 103 0.3× 16 1.6k
Chuang Lu United States 23 1.1k 1.2× 748 0.8× 659 1.2× 250 0.7× 169 0.5× 56 2.3k

Countries citing papers authored by Brahim Achour

Since Specialization
Citations

This map shows the geographic impact of Brahim Achour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brahim Achour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brahim Achour more than expected).

Fields of papers citing papers by Brahim Achour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brahim Achour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brahim Achour. The network helps show where Brahim Achour may publish in the future.

Co-authorship network of co-authors of Brahim Achour

This figure shows the co-authorship network connecting the top 25 collaborators of Brahim Achour. A scholar is included among the top collaborators of Brahim Achour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brahim Achour. Brahim Achour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Achour, Brahim, et al.. (2025). Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption. British Journal of Clinical Pharmacology. 91(7). 2028–2044.
4.
Rostami‐Hodjegan, Amin, Zubida M. Al‐Majdoub, Ka Lai Yee, et al.. (2024). Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment. Clinical Pharmacology & Therapeutics. 116(3). 814–823. 5 indexed citations
5.
Prasad, Bhagwat, Zubida M. Al‐Majdoub, Christine Wegler, Amin Rostami‐Hodjegan, & Brahim Achour. (2024). Quantitative Proteomics for Translational Pharmacology and Precision Medicine: State of The Art and Future Outlook. Drug Metabolism and Disposition. 52(11). 1208–1216. 1 indexed citations
6.
Al‐Majdoub, Zubida M., et al.. (2022). Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters. Journal of Pharmaceutical Sciences. 111(10). 2917–2929. 10 indexed citations
7.
Achour, Brahim, Pauline Gosselin, Jean Terrier, et al.. (2022). Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities. Clinical Pharmacology & Therapeutics. 111(6). 1268–1277. 22 indexed citations
8.
Barber, Jill, et al.. (2022). Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters. Drug Metabolism and Disposition. 50(6). 762–769. 6 indexed citations
9.
El‐Khateeb, Eman, et al.. (2022). Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease. Journal of Proteomics. 263. 104601–104601. 10 indexed citations
10.
Al‐Majdoub, Zubida M., Daniel Scotcher, Brahim Achour, et al.. (2021). Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics. Clinical Pharmacology & Therapeutics. 110(5). 1389–1400. 23 indexed citations
11.
El‐Khateeb, Eman, Adam S. Darwich, Brahim Achour, Varinder Athwal, & Amin Rostami‐Hodjegan. (2021). Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment. Alimentary Pharmacology & Therapeutics. 54(4). 388–401. 38 indexed citations
12.
El‐Khateeb, Eman, Zubida M. Al‐Majdoub, Amin Rostami‐Hodjegan, Jill Barber, & Brahim Achour. (2021). Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes. Drug Metabolism and Disposition. 49(8). 610–618. 19 indexed citations
13.
Neuhoff, Sibylle, Matthew D. Harwood, Amin Rostami‐Hodjegan, & Brahim Achour. (2021). Application of proteomic data in the translation of in vitro observations to associated clinical outcomes. Drug Discovery Today Technologies. 39. 13–22. 8 indexed citations
14.
Darwich, Adam S., Thomas M. Polasek, Jeffrey K Aronson, et al.. (2020). Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy. The Annual Review of Pharmacology and Toxicology. 61(1). 225–245. 109 indexed citations
15.
Couto, Narciso, Zubida M. Al‐Majdoub, Brahim Achour, et al.. (2020). Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine. Drug Metabolism and Disposition. 48(4). 245–254. 77 indexed citations
16.
Al‐Majdoub, Zubida M., et al.. (2020). Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liver. Xenobiotica. 50(10). 1208–1219. 8 indexed citations
17.
El‐Khateeb, Eman, Brahim Achour, Daniel Scotcher, et al.. (2020). Scaling Factors for Clearance in Adult Liver Cirrhosis. Drug Metabolism and Disposition. 48(12). 1271–1282. 19 indexed citations
18.
Wegler, Christine, Fabienne Z. Gaugaz, Tommy B. Andersson, et al.. (2016). Protein quantification of human hepatic drug transporters and metabolizing enzymes: an inter-laboratory and methodological comparison. Drug Metabolism Reviews. 48. 98–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026